Schrödinger Investor Relations Material
Latest events
Q4 2023
Schrödinger
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Schrödinger Inc
Access all reports
Segment Data
Access more data
Revenue by
Business area
Software products and services
Drug discovery
Expenses by
Financials
Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The Company's solutions enable life science researchers to identify likeliest candidates from compound libraries and screen them against biological targets in the systems biology environment. Schrödinger Inc. was founded in 1990 and is based in New York.
Key slides for Schrödinger Inc
Q4 2023
Schrödinger Inc
Q2 2023
Schrödinger Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States